Familial hypercholesterolemia
Familial hypercholesterolemia (FH) is an autosomal dominant genetic disease. The pathogenesis of this disease is the absence or abnormality of LDL receptors on the cell membrane surface, which leads to abnormal LDL metabolism in the body, resulting in increased plasma total cholesterol (TC) levels and low-density lipoprotein-cholesterol (LDL-C) levels.
Related Drugs
Pravastatin Sodium
Indication: Lipid-regulating drugs are suitable for patients with primary hypercholesterolemia that cannot be controlled by dietary restrictions or patients with hypertriglyceridemia (type IIa and IIb), hyperlipidemia, and familial hypercholesterolemia.
Manufacturer:
Shanghai Techwell Biopharmaceutical Co., Ltd.
Pravastatin Sodium
Indication: Lipid-regulating drugs are suitable for patients with primary hypercholesterolemia that cannot be controlled by dietary restrictions or patients with hypertriglyceridemia (type IIa and IIb), hyperlipidemia, and familial hypercholesterolemia.
Manufacturer:
Zhejiang Hisun Pharmaceutical Co., Ltd.
Rosuvastatin calcium dispersible tablets
Indication: 1. This product is suitable for primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia) or mixed dyslipidemia (type IIb) whose dyslipidemia cannot be properly controlled by diet control and other non-drug treatments (such as exercise therapy, weight loss). 2. This product is also suitable for patients with homozygous familial hypercholesterolemia as an adjuvant treatment for diet control and other lipid-lowering measures (such as LDL removal therapy), or when these methods are not applicable.
Manufacturer:
Lunan BETTER Pharmaceutical Co., Ltd.
Simvastatin Capsules
Indication: Used for the treatment of hypercholesterolemia and combined hyperlipidemia; prevention and treatment of coronary heart disease and cerebral stroke.
Manufacturer:
Hubei Shubang Pharmaceutical Co., Ltd.
Zocor Simvastatin Tablets
Indication: Used for patients with hypercholesterolemia, primary hypercholesterolemia, heterozygous familial hypercholesterolemia or mixed hypercholesterolemia, etc.
Pitavastatin calcium
Indication: Lowering blood lipids (hypercholesterolemia, familial hypercholesterolemia).
Manufacturer:
Xuzhou Wanbang Jinqiao Pharma Co., Ltd.
Atorvastatin Calcium Tablets
Indication: 1. Hypercholesterolemia Patients with primary hypercholesterolemia, including familial hypercholesterolemia (heterozygous type) or mixed hyperlipidemia (equivalent to type IIa and IIb of Fredrickson classification), can use this product to treat elevated total cholesterol, elevated low-density lipoprotein cholesterol, elevated apolipoprotein B and elevated triglycerides if dietary therapy and other non-drug treatments are unsatisfactory. In patients with homozygous familial hypercholesterolemia, atorvastatin calcium can be used in combination with other lipid-lowering therapies (such as LDL plasma dialysis) or alone (when no other treatment is available) to lower total cholesterol and low-density lipoprotein cholesterol. 2. Coronary heart disease Coronary heart disease or coronary heart disease-related critical illnesses (such as diabetes, symptomatic atherosclerotic disease, etc.) combined with high
Atorvastatin Calcium Tablets
Indication: 1. Hypercholesterolemia Patients with primary hypercholesterolemia, including familial hypercholesterolemia (heterozygous type) or mixed hyperlipidemia (equivalent to type IIa and IIb of Fredrickson classification), can use this product to treat elevated total cholesterol, elevated low-density lipoprotein cholesterol, elevated apolipoprotein B and elevated triglycerides if dietary therapy and other non-drug treatments are unsatisfactory. In patients with homozygous familial hypercholesterolemia, atorvastatin calcium can be used in combination with other lipid-lowering therapies (such as LDL plasma dialysis) or alone (when no other treatment is available) to lower total cholesterol and low-density lipoprotein cholesterol. 2. Coronary heart disease Coronary heart disease or coronary heart disease-related critical illnesses (such as diabetes, symptomatic atherosclerotic disease, etc.) combined with high
Rosuvastatin calcium
Indication: It is suitable for the adjuvant treatment of patients with primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia) or mixed dyslipidemia (type IIb) when diet or exercise therapy is not ideal. It is also suitable for patients with homozygous familial hypercholesterolemia and can be used alone or in combination with diet or other lipid-lowering methods (such as LDL removal).
Rosuvastatin calcium
Indication: It is suitable for the adjuvant treatment of patients with primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia) or mixed dyslipidemia (type IIb) when diet or exercise therapy is not ideal. It is also suitable for patients with homozygous familial hypercholesterolemia and can be used alone or in combination with diet or other lipid-lowering methods (such as LDL removal).
Manufacturer:
Shandong Newtime Pharmaceutical Co., Ltd.